240 related articles for article (PubMed ID: 26490982)
21. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
22. A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma.
Tsuneoka M; Teye K; Arima N; Soejima M; Otera H; Ohashi K; Koga Y; Fujita H; Shirouzu K; Kimura H; Koda Y
J Biol Chem; 2005 May; 280(20):19977-85. PubMed ID: 15774466
[TBL] [Abstract][Full Text] [Related]
23. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
25. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
26. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
[TBL] [Abstract][Full Text] [Related]
27. Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma.
Wang J; Liu Z; Wang Z; Wang S; Chen Z; Li Z; Zhang M; Zou J; Dong B; Gao J; Shen L
Cancer Lett; 2018 Apr; 419():64-74. PubMed ID: 29366803
[TBL] [Abstract][Full Text] [Related]
28. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
30. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells.
Yu L; Wu WK; Li ZJ; Li HT; Wu YC; Cho CH
Int J Cancer; 2009 Dec; 125(11):2540-6. PubMed ID: 19623651
[TBL] [Abstract][Full Text] [Related]
32. miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.
Li J; Liang Y; Lv H; Meng H; Xiong G; Guan X; Chen X; Bai Y; Wang K
Gene; 2017 Aug; 625():1-9. PubMed ID: 28476684
[TBL] [Abstract][Full Text] [Related]
33. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
[TBL] [Abstract][Full Text] [Related]
34. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of AUF1 is involved in the proliferation of esophageal squamous cell carcinoma through GCH1.
Gao Y; Wang W; Cao J; Wang F; Geng Y; Cao J; Xu X; Zhou J; Liu P; Zhang S
Int J Oncol; 2016 Nov; 49(5):2001-2010. PubMed ID: 27826622
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
37. Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.
Wang L; Xing J; Cheng R; Shao Y; Li P; Zhu S; Zhang S
PLoS One; 2015; 10(5):e0126319. PubMed ID: 25950810
[TBL] [Abstract][Full Text] [Related]
38. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.
Sun Y; Shi N; Lu H; Zhang J; Ma Y; Qiao Y; Mao Y; Jia K; Han L; Liu F; Li H; Lin Z; Li X; Zhao X
Carcinogenesis; 2014 Sep; 35(9):1941-50. PubMed ID: 24510239
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma.
Li Y; Chen L; Nie CJ; Zeng TT; Liu H; Mao X; Qin Y; Zhu YH; Fu L; Guan XY
Cancer Res; 2011 Oct; 71(19):6106-15. PubMed ID: 21844183
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of 5S rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and inhibits proliferation of esophageal squamous carcinoma cells.
Wang X; Ren Y; Wang Z; Xiong X; Han S; Pan W; Chen H; Zhou L; Zhou C; Yuan Q; Yang M
FEBS Lett; 2015 Dec; 589(24 Pt B):3989-97. PubMed ID: 26606907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
